(Q38121773)

29 August 2017

Advances in the genetics of Parkinson disease (English)

1 reference

29 August 2017

1 reference

2

1 reference

29 August 2017

Joanne Trinh

1

1 reference

PubMed ID

23857047

29 August 2017

language of work or name

English

0 references

publication date

16 July 2013

1 reference

29 August 2017

Nature Reviews Neurology

1 reference

29 August 2017

9

1 reference

29 August 2017

445-454

1 reference

29 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2013.132

29 August 2017

0 references

cites work

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Parkinson's disease. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Parkinson's disease. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The Parkinson's complex: parkinsonism is just the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

100 years of Lewy pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Neuropathology underlying clinical variability in patients with synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genetics of Parkinson disease: paradigm shifts and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Postencephalitic parkinsonism--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Parkinson disease in twins: an etiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Heritability of Parkinson disease in Swedish twins: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A novel α-synuclein missense mutation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Expanding the clinical phenotype of SNCA duplication carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genomic investigation of alpha-synuclein multiplication and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Lewy bodies and parkinsonism in families with parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

SNCA variants are associated with increased risk for multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Cellular effects of LRRK2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Lrrk2 and Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

LRRK2 I2020T mutation is associated with tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Disentangling the role of the tau gene locus in sporadic tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Linkage disequilibrium and association of MAPT H1 in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Evolutionary toggling of the MAPT 17q21.31 inversion region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Translation initiator EIF4G1 mutations in familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

PINK1-linked parkinsonism is associated with Lewy body pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

PINK1 mutations and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Recent advances in retromer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

VPS35 mutations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

VPS35 mutation in Japanese patients with typical Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Homozygous deletion of an 80 kb region comprising part of DNAJC6 and LEPR genes on chromosome 1P31.3 is associated with early onset obesity, mental retardation and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The link between the GBA gene and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Glucosidase-beta variations and Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Association between Parkinson's disease and the HLA-DRB1 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide association study confirms extant PD risk loci among the Dutch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

DCTN1 mutations in Perry syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Mutant dynactin in motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

"Nature versus nurture" and incompletely penetrant mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Pathology of PD in monozygotic twins with a 20-year discordance interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Common genetic variation and human traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genomic and personalized medicine: foundations and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Measures of autozygosity in decline: globalization, urbanization, and its implications for medical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

In vivo silencing of alpha-synuclein using naked siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Autophagy: many paths to the same end.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Interplay of LRRK2 with chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Disruption of protein quality control in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Distinct initial SNARE configurations underlying the diversity of exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Molecular machines governing exocytosis of synaptic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Monomeric synucleins generate membrane curvature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A presynaptic inositol-5-phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Recruitment of endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after fission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Regulation of endosomal clathrin and retromer-mediated endosome to Golgi retrograde transport by the J-domain protein RME-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Recycle your receptors with retromer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Vps35 mediates vesicle transport between the mitochondria and peroxisomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The retromer complex - endosomal protein recycling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Ceramide triggers budding of exosome vesicles into multivesicular endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Screening for VPS35 mutations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

G. H. Hardy (1908) and Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The role of large pedigrees in an era of high-throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The use of next-generation sequencing in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Parkinsonism, FXTAS, and FMR1 premutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

-Synuclein and Parkinson disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Lrrk2 pathogenic substitutions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

alpha-synuclein gene haplotypes are associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Atypical Parkinsonism and SCA8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Description of Parkinson's disease as a clinical syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Identification of VPS35 mutations replicated in French families with Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Frequency of the D620N mutation in VPS35 in Parkinson disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Recruitment dynamics of GAK and auxilin to clathrin-coated pits during endocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Characterization of PLA2G6 as a locus for dystonia-parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

Chaperoning the SNAREs: a role in preventing neurodegeneration?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.132

The spectrum of levodopa-induced dyskinesias

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23857047

12 December 2020

inferred from PubMed ID database lookup

Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23857047

12 December 2020

inferred from PubMed ID database lookup

Molecular chaperones in Parkinson's disease--present and future

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23857047

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRNEUROL.2013.132

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4mpoxeygzfb6hn7hkgrtqmv7vy

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1012629818

0 references

Fatcat ID

release_4mpoxeygzfb6hn7hkgrtqmv7vy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4mpoxeygzfb6hn7hkgrtqmv7vy

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/4mpoxeygzfb6hn7hkgrtqmv7vy

30 July 2022